Success Stories

Learn how other UK businesses have used external finance to reach their ambition

Here’s just some of the tens of thousands of smaller businesses funded through our partners, with the support of British Business Bank’s programmes.

Growth Guarantee Scheme

Câr-y-Môr

Câr-y-Môr is the first community-owned regenerative ocean farm in Wales. With a diverse membership of over 300 individuals from various backgrounds, Câr-y-Môr has become a shining example of community-driven sustainability and innovation.

Read the success story about Câr-y-Môr
Filter success stories
Filter Close filters
Filter success stories
Finance type
Sector
Nation/Region
Programme
Partner
Debt Funds

Vyta Secure Ltd

Vyta provides secure IT Asset Disposition (ITAD) services to clients throughout the UK & Ireland. Started in 2001 and originally based in Northern Ireland, it expanded to Dublin in 2008.

Debt Funds

Butternut Box

Butternut Box is a direct to consumer fresh dog food subscription company based in the UK, Ireland & Netherlands. From its in-house production site in Bassetlaw, It manufactures and delivers a range of freshly cooked human grade meals, with a personalized dietary offering driven by its proprietary tech platform. It is the leading fresh pet food player in Europe.

Managed Funds Programme

Beauty Pie

Beauty Pie is a beauty and wellness brand that gives its members access to owned products sourced from the world’s best labs at up to 70% off traditional retail prices.

FinTech

Hook & Son

British Business Investments delivery partner FOLK2FOLK specialises in providing finance to underserved smaller businesses within regional areas of the UK.

ENABLE Funding

Gymfinity Kids

Gymfinity Kids, established in 2017, operate a series of activity clubs for children aged 3+ across six sites.

Patient Capital Funds

Xampla

Xampla has developed an entirely new generation of materials, made from plants, that replaces plastics.

Patient Capital Funds

Ori Biotech

Ori Biotech’s mission is to eliminate barriers to patient access of cell and gene therapies (CGTs) through the use of innovation and by rethinking how those therapies are manufactured.

Patient Capital Funds

Quantexa

Quantexa is a data and analytics specialist which has developed a software platform for organisations to help them make meaningful, evidence-based decision using data and machine learning.

Patient Capital Funds

Thought Machine

Thought Machine is providing the next generation of core banking platforms using software it has built natively for cloud infrastructure to help banks move away from a reliance on outdated IT infrastructure.

Patient Capital Funds

Alchemab Therapeutics

Alchemab Therapeutics is a healthcare company that is harnessing the power of naturally protective antibodies to develop novel products for patients with hard-to-treat diseases.

Regional Angels

Elasmogen

Part of a cluster of biotech companies in Aberdeen, Elasmogen uses its bespoke technology platform to isolate innovative drugs for treating cancers and auto-immune diseases.